Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis

Kidney International

Volumn 67, Issue 5, 2005, Pages 1821-1829

  Saga, Daisuke ^a   Sakatsume, Minoru ^a   Ogawa, Asa ^a   Tsubata, Yutaka ^a   Kaneko, Yoshikatsu ^a   Kuroda, Takeshi ^a   Sato, Fuminori ^a   Ajiro, Junya ^a   Kondo, Daisuke ^a   Miida, Takashi ^a   Narita, Ichiei ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Antiglomerular basement membrane glomerulonephritis; Bezafibrate; Fibrate; Glomerulonephritis; Peroxisome proliferator activated receptors

Indexed keywords

BEZAFIBRATE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RAT; SPLEEN CELL; TISSUE INJURY;

EID: 20244381833     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00280.x     Document Type: Article

References (40)

1. ISSEMANN I, GREEN S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650, 1990
2. BRAISSANT O, FOUFELLE F, SCOTTO C, et al: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137:354-366, 1996
3. GUAN Y, BREYER MD: Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int 60:14-30, 2001
4. RICOTE M, LI AC, WILLSON TM, et al: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82, 1998
5. JIANG C, TING AT, SEED B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998
6. ELANGBAM CS, TYLER RD, LIGHTFOOT RM: Peroxisome proliferator-activated receptors in atherosclerosis and inflammation-an update. Toxicol Pathol 29:224-231, 2001
7. DELERIVE P, FRUCHART JC, STAELS B: Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169:453-459, 2001
8. CLARK RB: The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400, 2002
9. DAYNES RA, JONES DC: Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759, 2002
10. OATES JC, REILLY CM, CROSBY MB, et al: Peroxisome proliferator-activated receptor gamma agonists: Potential use for treating chronic inflammatory diseases. Arthritis Rheum 46:598-605, 2002
11. MURAI T, YAMADA T, MIIDA T, et al: Fenofibrate inhibits reactive amyloidosis in mice. Arthritis Rheum 46:1683-1688, 2002
12. MARUYAMA S, KATO K, KODAMA M, et al: Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb 9:87-92, 2002
13. MARX N, SUKHOVA GK, COLLINS T, et al: PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99:3125-3131, 1999
14. NEVE BP, CORSEAUX D, CHINETTI G, et al: PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103:207-212, 2001
15. UNANUE ER, DIXON FJ: Experimental glomerulonephritis: Immunological events and pathogenetic mechanisms. Adv Immunol 6:1-90, 1967
16. KAWASAKI K, YAOITA E, YAMAMOTO T, et al: Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 41:1517-1526, 1992
17. KAWASAKI K, YAOITA E, YAMAMOTO T, et al: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150:1074-1083, 1993
18. FUJINAKA H, YAMAMOTO T, FENG L, et al: Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol 158:4978-4983, 1997
19. KURODA T, KAWASAKI K, OITE T, et al: Nephrotoxic serum nephritis in nude rats: The role of cell-mediated immunity. Nephron 68:360-365, 1994
20. YAMAMOTO T, FUJINAKA H, KAWASAKI K, et al: CD8+ lymphocytes play a central role in the development of anti-GBM nephritis through induction of ICAM-I and chemokines in WKY rats. Contrib Nephrol 118:109-112, 1996
21. KANEKO Y, SAKATSUME M, XIE Y, et al: Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis. J Immunol 170:3377-3385, 2003
22. KOCKX M, GERVOIS PP, POULAIN P, et al: Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha. Blood 93:2991-2998, 1999
23. CASTOLDI D, MONZANI V, TOFANETTI O: Determination of bezafibrate in human plasma and urine by high-performance liquid chromatography. J Chromatogr 344:259-265, 1985
24. HOLDEN PR, TUGWOOD JD: Peroxisome proliferator-activated receptor alpha: Role in rodent liver cancer and species differences. J Mol Endocrinol 22:1-8, 1999
25. DELERIVE P, DE BOSSCHER K, BESNARD S, et al: Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048-32054, 1999
26. DELERIVE P, GERVOIS P, FRUCHART JC, et al: Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 275:36703-36707, 2000
27. CUNARD R, DICAMPLI D, ARCHER DC, et al: WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J Immunol 169:6806-6812, 2002
28. STAELS B, KOENIG W, HABIB A, et al: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393:790-793, 1998
29. POYNTER ME, DAYNES RA: Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273:32833-32841, 1998
30. WOERLY G, HONDA K, LOYENS M, et al: Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 198:411-421, 2003
31. CERNUDA-MOROLLON E, RODRIGUEZ-PASCUAL F, KLATT P, et al: PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: Implications for mesangial cell activation by cytokines. J Am Soc Nephrol 13:2223-2231, 2002
32. CUNARD R, RICOTE M, DICAMPLI D, et al: Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168:2795-2802, 2002
33. YANG T, MICHELE DE, PARK J, et al: Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 277:F966-F973, 1999
34. ISHIZUKA T, ITO O, TAN L, et al: Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. Hypertens Res 26:929-936, 2003
35. KAMIJO Y, HORA K, TANAKA N, et al: Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules. J Am Soc Nephrol 13:1691-1702, 2002
36. PORTILLA D, DAI G, PETERS JM, et al: Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278:F667-F675, 2000
37. LI S, WU P, YARLAGADDA P, et al: PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am J Physiol Renal Physiol 286:F572-F580, 2004
38. PETERS JM, AOYAMA T, BURNS AM, et al: Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice. Biochim Biophys Acta 1632:80-89, 2003
39. HARAGUCHI K, SHIMURA H, ONAYA T: Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activators. Clin Exp Nephrol 7:27-32, 2003
40. TSUBOYAMA-KASAOKA N, TAKAHASHI M, KIM H, et al: Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding Or fibrate administration in mice. Biochem Biophys Res Commun 257:879-885, 1999